Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.58 USD | +0.26% | +30.28% | -20.49% |
02:43pm | Zai Lab's Supplemental Application for Autoimmune Disease Treatment Accepted by China Regulator | MT |
May. 13 | Asian Equities Traded in the US as American Depositary Receipts Begin Week Higher | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.49% | 2.13B | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
-13.31% | 32.81B | |
+52.41% | 25B | |
-17.30% | 15.29B | |
-42.45% | 11.61B | |
-10.48% | 11.49B | |
+6.14% | 8.98B | |
-7.72% | 8.23B |
- Stock Market
- Equities
- ZLAB Stock
- News Zai Lab Limited
- Citigroup Adjusts Price Target on Zai Lab to $127 From $199, Maintains Buy Rating